脑室内组织型纤溶酶原激活剂与动脉瘤性蛛网膜下腔出血伴脑室铸型患者的分流依赖
该回顾性研究基于PBRAT数据库纳入806例aSAH患者,比较有无IVH及脑室铸型者的分流依赖风险,并分析脑室内tPA对铸型患者的影响。结果显示IVH与脑室铸型均独立增加分流风险,而脑室内tPA治疗与分流依赖风险降低相关。
要点
- aSAH患者中IVH发生率69.6%,IVH独立增加分流依赖风险(OR 7.8)。
- IVH患者中脑室铸型占14.3%,铸型独立预测分流依赖(OR 3.0)。
- 脑室铸型患者接受脑室内tPA后分流依赖风险降低(OR 0.30)。
核心结论
- aSAH患者脑室铸型与慢性脑积水分流依赖风险增加相关,脑室内tPA治疗可降低该风险。
研究设计与样本
- 回顾性队列研究,基于PBRAT数据库纳入2010年8月1日至2019年7月31日治疗的806例aSAH患者。
主要发现
- 806例aSAH患者中561例(69.6%)存在IVH,IVH组分流率25.7% vs 无IVH组4.1%(P < .001)。
- 多因素logistic回归显示IVH独立增加分流风险(OR 7.8,95% CI 3.8-16.2,P < .001)。
- IVH患者中80例(14.3%)存在广泛脑室铸型,倾向评分校正后铸型独立预测分流(OR 3.0,95% CI 1.8-4.9,P < .001)。
临床怎么用
- 对aSAH伴IVH及脑室铸型患者,可考虑脑室内tPA以降低长期分流依赖风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Patients with intraventricular hemorrhage (IVH) are at higher risk of hydrocephalus requiring an external ventricular drain and long-term ventriculoperitoneal shunt placement. OBJECTIVE: To investigate whether intraventricular tissue plasminogen activator (tPA) administration in patients with ventricular casting due to IVH reduces shunt dependence. METHODS: Patients from the Post-Barrow Ruptured Aneurysm Trial (PBRAT) database treated for aneurysmal subarachnoid hemorrhage (aSAH) from August 1, 2010, to July 31, 2019, were retrospectively reviewed. Patients with and without IVH were compared. A second analysis compared IVH patients with and without ventricular casting. A third analysis compared patients with ventricular casting with and without intraventricular tPA treatment. The primary outcome was chronic hydrocephalus requiring permanent shunt placement. RESULTS: Of 806 patients hospitalized with aSAH, 561 (69.6%) had IVH. IVH was associated with a higher incidence of shunt placement (25.7% vs 4.1%, P < .001). In multivariable logistic regression analysis, IVH was independently associated with increased likelihood of shunt placement (odds ratio [OR]: 7.8, 95% CI: 3.8-16.2, P < .001). Generalized ventricular casting was present in 80 (14.3%) patients with IVH. In a propensity-score adjusted analysis, generalized ventricular casting was an independent predictor of shunt placement (OR: 3.0, 95% CI: 1.8-4.9, P < .001) in patients with IVH. Twenty-one patients with ventricular casting received intraventricular tPA. These patients were significantly less likely to require a shunt (OR: 0.30, 95% CI: 0.010-0.93, P = .04). CONCLUSION: Ventricular casting in aSAH patients was associated with an increased risk of chronic hydrocephalus and shunt dependency. However, this risk decreased with the administration of intraventricular tPA.
引用
- Catapano JS, Rumalla K, Karahalios K, et al. Intraventricular Tissue Plasminogen Activator and Shunt Dependency in Aneurysmal Subarachnoid Hemorrhage Patients With Cast Ventricles. Neurosurgery. 2021. PMID: 34460915. doi:10.1093/neuros/nyab333
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。